Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases.
AffiliationRespiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland.
MeSHGene Expression Regulation
MetadataShow full item record
CitationTherapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. 2012, 10 (3):359-68 Expert Rev Anti Infect Ther
JournalExpert review of anti-infective therapy
AbstractmiRNAs are short, nonprotein coding RNAs that regulate target gene expression principally by causing translational repression and/or mRNA degradation. miRNAs are involved in most mammalian biological processes and have pivotal roles in controlling the expression of factors involved in basal and stimulus-induced signaling pathways. Considering their central role in the regulation of gene expression, miRNAs represent therapeutic drug targets. Here we describe how miRNAs are involved in the regulation of aspects of innate immunity and inflammation, what happens when this goes awry, such as in the chronic inflammatory lung diseases cystic fibrosis and asthma, and discuss the current state-of-the-art miRNA-targeted therapeutics.
- MicroRNAs in inflammatory lung disease--master regulators or target practice?
- Authors: Oglesby IK, McElvaney NG, Greene CM
- Issue date: 2010 Oct 28
- MicroRNA-29: a potential therapeutic target for systemic sclerosis.
- Authors: Peng WJ, Tao JH, Mei B, Chen B, Li BZ, Yang GJ, Zhang Q, Yao H, Wang BX, He Q, Wang J
- Issue date: 2012 Sep
- Role of microRNAs in vascular diseases, inflammation, and angiogenesis.
- Authors: Urbich C, Kuehbacher A, Dimmeler S
- Issue date: 2008 Sep 1
- Involvement of microRNAs in physiological and pathological processes in the lung.
- Authors: Tomankova T, Petrek M, Kriegova E
- Issue date: 2010 Nov 23
- Therapeutic advances in MicroRNA targeting.
- Authors: Montgomery RL, van Rooij E
- Issue date: 2011 Jan